Projects per year
Fingerprint Dive into the research topics where Nagaraj Nagathihalli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Pancreatic Neoplasms
Medicine & Life Sciences
Cathepsin B
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Adenocarcinoma
Medicine & Life Sciences
Goats
Medicine & Life Sciences
Mouth Neoplasms
Medicine & Life Sciences
Cells
Chemical Compounds
Epithelial-Mesenchymal Transition
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2016 2018
- 1 Finished
Targeting cytokine mediated CREB activation in pancreatic cancer
7/5/16 → 6/30/18
Project: Research project
Response Elements
Pancreatic Neoplasms
Cyclic AMP
Cytokines
Adenocarcinoma
Research Output 2001 2019
Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue
McPherson, L. A., Troccoli, C. I., Ji, D., Bowles, A. E., Gardiner, M. L., Mohsen, M. G., Nagathihalli, N., Nguyen, D., Robbins, D. J., Merchant, N., Kool, E. T., Rai, P. & Ford, J. M., Jan 1 2019, In : DNA Repair. 102644.Research output: Contribution to journal › Article
Colonic Neoplasms
Guanine
Adenosine Triphosphate
Tissue
Lung
New mechanistic insights into modifiable risk factors that promote pancreatic cancer
Srinivasan, S., Dosch, A. R. & Nagathihalli, N., Mar 29 2019, In : Oncotarget. 10, 25, p. 2417-2418 2 p.Research output: Contribution to journal › Editorial
Open Access
Pancreatic Neoplasms
Smoking
Alcohols
Src kinase inhibition restores E-cadherin expression in Dasatinib-sensitive pancreatic cancer cells
Dosch, A. R., Dai, X., Gaidarski, A. A., Shi, C., Castellanos, J. A., Vansaun, M., Merchant, N. & Nagathihalli, N., Feb 1 2019, In : Oncotarget. 10, 10, p. 1056-1069 14 p.Research output: Contribution to journal › Article
src-Family Kinases
Cadherins
Pancreatic Neoplasms
Adenocarcinoma
Gastropoda
6
Citations
(Scopus)
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Totiger, T. M., Srinivasan, S., Jala, V. R., Lamichhane, P., Dosch, A. R., Gaidarski, A. A., Joshi, C., Rangappa, S., Castellanos, J., Vemula, P. K., Chen, X., Kwon, D., Kashikar, N., Vansaun, M., Merchant, N. & Nagathihalli, N., Feb 1 2019, In : Molecular cancer therapeutics. 18, 2, p. 301-311 11 p.Research output: Contribution to journal › Article
Pancreatic Neoplasms
Phosphatidylinositol 3-Kinases
Adenocarcinoma
70-kDa Ribosomal Protein S6 Kinases
gemcitabine
4
Citations
(Scopus)
Inverse correlation of STAT3 and MEK signaling mediates resistance to Ras pathway inhibition in pancreatic cancer
Nagathihalli, N., Castellanos, J. A., Lamichhane, P., Messaggio, F., Shi, C., Dai, X., Rai, P., Chen, X., Vansaun, M. & Merchant, N., Nov 1 2018, In : Cancer Research. 78, 21, p. 6235-6246 12 p.Research output: Contribution to journal › Article
Mitogen-Activated Protein Kinase Kinases
Pancreatic Neoplasms
Adenocarcinoma
Heterografts
Neoplasms